⌘K

Cidara Therapeutics, Inc. (CDTX)

$11.80 -3.50% $-0.43 Healthcare

Cidara Therapeutics, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of long-acting anti-infectives for the treatment and prevention of infectious diseases and oncology in the United States. The company's lead product candidate is rezafungin acetate, a novel molecule in the echinocandin class of antifungals for the treatment and prevention of invasive fungal infections, including candidemia and invasive candidiasis, which are fungal infections associated with high mortality rates. It also advances its Cloudbreak platform to develop conjugates for the prevention and treatment of influenza and other viral infections, such as RSV, HIV, and the SARS-CoV-2 strains causing COVID-19. The company was formerly known as K2 Therapeutics, Inc. and changed its name to Cidara Therapeutics, Inc. in July 2014. Cidara Therapeutics, Inc. was incorporated in 2012 and is based in San Diego, California.

Market cap

$83.07M

CEO

Dr. Jeffrey L. Stein Ph.D.

Full time employees

89.00

Headquarters

San Diego, CA

IPO Date

Apr 15, 2015

Price-to-earnings (PE) Ratio

-0.48

Earnings-per-share (EPS)

$-24.60

Cash ratio (TTM)

0.44

Current ratio (TTM)

0.72

Net profit margin (TTM)

-78.63%

PE ratio (TTM)

-1.43

PEG ratio (TTM)

-0.07

Price-to-book ratio (TTM)

-2.93

Price-to-sales ratio (TTM)

1.13

Quick ratio (TTM)

0.55

Return on assets (TTM)

-69.17%

Return on equity (TTM)

5,747.20%

Similar stocks (4)

Clearside Biomedical, Inc.

CLSD

$1.31 6.50% $0.08

Downtrend

CytomX Therapeutics, Inc.

CTMX

$1.21 -1.63% $-0.02

Downtrend

GlycoMimetics, Inc.

GLYC

$0.16 -4.59% $-0.00

Downtrend

TRACON Pharmaceuticals, Inc.

TCON

$0.06 9.09% $0.00

Downtrend

ETF Exposure (11)

iShares Micro-Cap ETF

IWC

0.01321%

$122.64 -0.28% $-0.34

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.45 0.51% $0.25

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.44 0.51% $0.25

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.44 0.51% $0.25

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$134.52 1.86% $2.45

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.10 0.71% $0.68

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.07 0.71% $0.68

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.94 0.72% $0.96

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$277.72 0.18% $0.50

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.92 0.72% $0.96

Uptrend

Vanguard Extended Market Index Fund

VXF

$178.36 0.55% $0.97

Uptrend

Downtrend

Similar stocks (4)

Clearside Biomedical, Inc.

CLSD

$1.31 6.50% $0.08

Downtrend

CytomX Therapeutics, Inc.

CTMX

$1.21 -1.63% $-0.02

Downtrend

GlycoMimetics, Inc.

GLYC

$0.16 -4.59% $-0.00

Downtrend

TRACON Pharmaceuticals, Inc.

TCON

$0.06 9.09% $0.00

Downtrend

ETF Exposure (11)

iShares Micro-Cap ETF

IWC

0.01321%

$122.64 -0.28% $-0.34

Uptrend

Vanguard Balanced Index Fund Institutional Shares

VBAIX

$49.45 0.51% $0.25

Uptrend

Vanguard Balanced Index Fund Admiral Shares

VBIAX

$49.44 0.51% $0.25

Uptrend

Vanguard Balanced Index Fund

VBINX

$49.44 0.51% $0.25

Uptrend

Vanguard Extended Market Index Fund Institutional Shares

VIEIX

$134.52 1.86% $2.45

Uptrend

Vanguard Institutional Total Stock Market Index Fund Institutional Shares

VITNX

$96.10 0.71% $0.68

Uptrend

Vanguard Institutional Total Stock Market Index Fund

VITPX

$96.07 0.71% $0.68

Uptrend

Vanguard Total Stock Market Index Fund

VITSX

$134.94 0.72% $0.96

Uptrend

Vanguard Total Stock Market Index Fund

VTI

$277.72 0.18% $0.50

Uptrend

Vanguard Total Stock Market Index Fund

VTSAX

$134.92 0.72% $0.96

Uptrend

Vanguard Extended Market Index Fund

VXF

$178.36 0.55% $0.97

Uptrend